Top View
- Toll-Like Receptor 4-Mediated Signaling Regulates IL-7-Driven Proliferation and Differentiation of B-Cell Precursors
- TLR2 and TLR4 Surface and Gene Expression in White Blood Cells After Fasting and Oral Glucose, Lipid and Protein Challenges: Influence of Obesity and Sex Hormones
- A Protein Associated with Toll-Like Receptor 4 (PRAT4A) Regulates Cell Surface Expression of TLR4
- Transduction TLR4- Versus TLR2-Mediated Signal Domain
- CD14 Dependence of TLR4 Endocytosis and TRIF Signaling Displays Ligand Specificity and Is Dissociable in Endotoxin Tolerance
- Stimulation of TLR2 and TLR4 Differentially Skews the Balance of T Cells in a Mouse Model of Arthritis
- Parasite Specific Antibody Levels, Interferon-Γ and TLR2 and TLR4
- And RAGE-Independent Proinflammatory Response
- Cryptococcus Neoformans Capsular Glucuronoxylomannan Induces Expression of Fas Ligand in Macrophages1
- TLR4: the Winding Road to the Discovery of the LPS Receptor Jessica L
- Toll-Like Receptors
- Interaction of TLR4 and TLR8 in the Innate Immune Response Against Mycobacterium Tuberculosis
- Inflammation
- Autoimmune Encephalomyelitis TLR1, TLR4 Or TLR6 In
- Toll-Like Receptors: Regulators of the Immune Response in the Human Gut
- Activation of Toll-Like Receptors 2, 3, and 4 on Human Melanoma Cells Induces Inflammatory Factors
- Computationally Designed Bispecific MD2/CD14 Binding Peptides Show TLR4 Agonist Activity
- TLR8: the Forgotten Relative Revindicated
- Dendritic Cells License Regulatory B Cells to Produce IL-10 and Mediate Suppression of Antigen-Specific CD8 T Cells
- The Evolving Erythrocyte: Red Blood Cells As Modulators of Innate Immunity H
- TLR4-Mediated Signaling Pathways Toll-Like Receptor
- TLR2, TLR4 and TLR10 Shape the Cytokine and Chemokine Release of H
- Negative Regulation of Toll-Like Receptor 4 Signaling by IL-10–Dependent Microrna-146B
- Incremental Expression of Tlr4 Correlates with Mouse Resistance to Salmonella Infection and Fine Regulation of Relevant Immune Genes
- Inhibition of TLR4 Signaling Protects Mice from Sensory and Motor
- A TLR4 Agonist Improves Immune Checkpoint Blockade Treatment by Increasing the Ratio of Efector to Regulatory Cells Within the Tumor Microenvironment A
- A Systemically Administered, Conditionally Active TLR8 Agonist for the Treatment of HER2-Expressing Tumors Kara Moyes, Ty Brender, Sean W
- Role of TLR4 Receptor Complex in the Regulation of the Innate Immune Response by Fibronectin
- Toll-Like Receptor Polymorphisms in Malaria-Endemic Populations
- Differential Outcome of TRIF-Mediated Signaling in TLR4 and TLR3 Induced DC Maturation
- Functional Role of the Tlr4 Signaling Pathway in the Bone
- TLR4/MYD88-Dependent, LPS-Induced Synthesis of PGE2 by Macrophages Or Dendritic Cells Prevents Anti-CD3-Mediated CD95L Upregulation in T Cells
- CD95 Receptor Activation by Ligand-Induced Trimerization Is Independent of Its Partial Pre- Ligand Assembly
- Acylpolyamine Mygalin As a TLR4 Antagonist Based on Molecular Docking and in Vitro Analyses
- Ifns Activate Toll-Like Receptor Gene Expression in Viral Infections
- Regulatory Role of the TLR4/JNK Signaling Pathway in Sepsis‑Induced Myocardial Dysfunction
- Ethanol, TLR3, and TLR4 Agonists Have Unique Innate Immune Responses in Neuron-Like SH-SY5Y and Microglia-Like BV2
- Toll-Like Receptor 4 Signaling in the Ileum and Colon of Gnotobiotic Piglets Infected with Salmonella Typhimurium Or Its Isogenic ∆Rfa Mutants
- Correction for Wang Et Al., TLR4/MD-2 Activation by a Synthetic Agonist with No Similarity to LPS Downloaded by Guest on October 2, 2021 A
- Integrative Inflammasome Activity in the Regulation of Intestinal Mucosal Immune Responses
- And Toll-Like Agonists As Vaccine Adjuvants Charles Maisonneuvea, Sylvie Bertholetb, Dana J
- CD14/TLR4 in Sepsis Pathogenesis and Therapy
- Fas (CD95) Induces Rapid, TLR4/IRAK4-Dependent Release Of
- Determination of Genetic Variations of Toll-Like Receptor (TLR)
- Premetastatic Milieu Explained by TLR4 Agonist-Mediated Homeostatic Inflammation
- TLR3 Downregulation of TLR4 Signaling Via Ischemia/Reperfusion
- Activation and TLR Ligands in Recently Diagnosed Type 2 Diabetic Subjects